Bullish
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
Agenus Inc. has partnered exclusively with BAP Pharma to manage global access programs for its botensilimab (BOT) plus balstilimab (BAL) therapies. Th...